...
首页> 外文期刊>Clinical and vaccine immunology: CVI >Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.
【24h】

Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.

机译:增强免疫的检测灵敏度对麻风杆菌肽的反应遗传分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Although worldwide leprosy prevalence has been reduced considerably following multidrug therapy, new case detection rates remain relatively stable, suggesting that transmission of infection still continues. This calls for new efforts, among which is development of assays that can identify subclinical/early-stage Mycobacterium leprae-infected subjects, a likely source of transmission. Areas in which leprosy is endemic often lack sophisticated laboratories, necessitating development of field-friendly immunodiagnostic tests for leprosy, like short-term whole-blood assays (WBA). In classical, peripheral blood mononuclear cell (PBMC)-based gamma interferon (IFN-gamma) release assays, M. leprae peptides have been shown to discriminate in a more specific fashion than M. leprae proteins between M. leprae-exposed contacts and patients as opposed to healthy controls from the same area of endemicity. However, peptides induced significantly lower levels of IFN-gamma than did proteins, particularly when whole blood was used. Therefore, possibilities of specifically enhancing IFN-gamma production in response to M. leprae peptides in 24-h WBA were sought by addition of various cytokines and antibodies or by mannosylation of peptides. In addition, other cytokines and chemokines were analyzed as potential biomarkers in WBA. We found that only interleukin 12 (IL-12), not other costimulants, increased IFN-gamma production in WBA while maintaining M. leprae peptide specificity, as evidenced by lack of increase of IFN-gamma in control samples stimulated with IL-12 alone. The IL-12-induced increase in IFN-gamma was mainly mediated by CD4+ T cells that did not produce IL-2 or tumor necrosis factor (TNF). Mannosylation further allowed the use of 100-fold-less peptide. Although not statistically significantly, macrophage inflammatory protein 1beta (MIP-1beta) and macrophage c protein 1 (MCP-1) levels specific for M. leprae peptide tended to be increased by IL-12. IP-10 production was also found to be a useful marker of M. leprae peptide responses, but its production was enhanced by IL-12 nonspecifically. We conclude that IFN-gamma-based WBA combined with IL-12 represents a more sensitive and robust assay for measuring reactivity to M. leprae peptides.
机译:尽管全球麻风病流行大大降低了耐多药治疗后,新病例检出率保持相对稳定,这表明感染的传播仍在继续。其中开发的化验识别亚临床/早期分枝杆菌leprae-infected主题,一个可能的来源传播。往往缺乏先进的实验室,需要发展field-friendly为麻风病,immunodiagnostic测试短期的遗传分析(WBA)。古典、外周血单核细胞(PBMC)的γ干扰素(IFN-gamma)释放化验,麻风杆菌肽已被证明歧视更具体的方式比M。即麻风m . leprae-exposed之间的蛋白质接触和病人与健康控制同一地区的地方性流行。然而,肽诱导显著降低IFN-gamma水平比蛋白质,尤其是当使用全血。因此,具体的可能性加强应对IFN-gamma生产M。即麻风肽在24小时WBA被寻求添加各种细胞因子和抗体或mannosylation肽。细胞因子和趋化因子进行了分析在WBA的潜在生物标志物。白介素12 (il - 12),而不是其他costimulants,WBA IFN-gamma生产而增加维护麻风杆菌肽特异性,缺乏增长IFN-gamma证明了这一点控制样品刺激与il - 12。IL-12-induced IFN-gamma主要是增加由CD4 + T细胞,不产生2、肿瘤坏死因子(TNF)。Mannosylation进一步允许使用100倍——小肽。值得注意的是,巨噬细胞炎性蛋白质1β(MIP-1beta)和巨噬细胞c蛋白1具体对麻风杆菌肽(MCP-1)水平往往增加了il - 12。也被发现是一个有用的标志麻风杆菌肽反应,但其生产可以增强il - 12是非。IFN-gamma-based WBA结合il - 12代表一个更敏感的和健壮的检验测量反应性对麻风杆菌肽。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号